Veracyte (VCYT) Operating Leases (2019 - 2026)

Veracyte has disclosed Operating Leases across 8 years of filings, most recently posting $35.0 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $35.0 million, down 18.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.0 million (down 18.81% YoY), and the FY2025 annual result was $35.6 million, down 17.66% from the prior year.
• Operating Leases came in at $35.0 million for Q1 2026 at Veracyte, down from $35.6 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $50.6 million in Q2 2025 to a low of $7.5 million in Q4 2023.
• The 5-year median for Operating Leases is $14.0 million (2024), against an average of $22.4 million.
• Across the five-year window, Operating Leases sank 34.88% in 2022 and surged 474.58% in 2024, its largest moves.
• Veracyte's Operating Leases stood at $10.6 million in 2022, then dropped by 29.33% to $7.5 million in 2023, then soared by 474.58% to $43.2 million in 2024, then fell by 17.66% to $35.6 million in 2025, then declined by 1.73% to $35.0 million in 2026.
• The last three Operating Leases figures came in at $35.0 million (Q1 2026), $35.6 million (Q4 2025), and $36.2 million (Q3 2025), per Business Quant data.